Managing malignant pleural mesothelioma research study
We are conducting a research study aimed at learning more about how health professionals make decisions about treatment for patients with malignant pleural mesothelioma (MPM). An individual questionnaire has been designed for cancer nurse specialists who treat people with MPM.
We are seeking your assistance. If you agree to take part in this study, you will complete the questionnaire by clicking on the study link provided below. The online questionnaire will explore your perception of the use of chemotherapy for malignant mesothelioma patients and your views about why patients choose to have chemotherapy or not. Your responses are entirely confidential, and the researchers involved in the study will only see your confidential participant number, not your name.
Your involvement should take in total about 15-20 minutes of your time.
This study is being carried out under the auspices of the Centre for Medical Psychology and Evidence-based Decision-making (CeMPED) at the University of Sydney in conjunction with the Asbestos Diseases Research Institute. The people responsible for the study are:
A/Prof Janette Vardy, Medical Oncologist, Concord Repatriation General Hospital
Dr Haryana Dhillon, Behavioral Scientist, CeMPED
Dr Prunella Blinman, Medical Oncologist, Concord Repatriation General Hospital
Dr Steven Kao, Fellow, Asbestos Diseases Research Institute
Professor Nico van Zandwijk, Director, Asbestos Diseases Research Institute
This study has been approved by the Human Research Ethics Committee (CRGH) of the Sydney Local Health District. Any person with concerns or complaints about the conduct of this study should contact the Executive Officer on 02 9767 5622 and quote protocol number HREC/12/CRGH/122.
If you have any questions regarding the aims and procedures of this study please contact Anne Warby, Research Coordinator, on 02-9767 9816 during business hours or by email at email@example.com.